Phosphoric Acid

Phosphoric Acid

SCHEMBL4743258

CC(=O)NS(=O)(=O)c1ccsc1.CC(=O)NS(=O)(=O)c1ccsc1.O=P([O-])([O-])O.[Na+].[Na+]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
DHFR P00374 1/20 0.47
TSHR P16473 1/20 0.47
PKM P14618 2/20 0.44
HTT P42858 1/20 0.42
POLB P06746 1/20 0.41
PTGS2 P35354 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CA12 O43570 1/20 0.38
MMP2 P08253 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
EPHX2 P34913 1/20 0.38
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
EDNRA P25101 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6151670 0.73 CCR4 (0.43) SMN1; SMN2TDP1DHFRTSHRPOLB
SCHEMBL6793445 0.73 MMP2 (0.42) SMN1; SMN2TDP1DHFRTSHRALDH1A1
Acetic Acid SCHEMBL11498310 0.71 EDNRA (0.41) SMN1; SMN2HTTALDH1A1CA12CA9
Sulfacetamide SCHEMBL28122370 0.70 SMN1; SMN2 (0.86) SMN1; SMN2TDP1DHFRTSHRPKM
SCHEMBL3823660 0.68 SMN1; SMN2 (0.48) SMN1; SMN2HTTPTGS2ALDH1A1CA12
SCHEMBL4477501 0.67 KDM4E (0.47) SMN1; SMN2POLBPTGS2ALDH1A1HSD17B10
SCHEMBL5931251 0.67 SMN1; SMN2 (0.69) SMN1; SMN2TDP1DHFRTSHRPKM
SCHEMBL7541831 0.67 SMN1; SMN2 (0.69) SMN1; SMN2TDP1DHFRTSHRPKM
Sulfacetamide SCHEMBL40863 0.65 SMN1; SMN2 (1.00) SMN1; SMN2TDP1DHFRTSHRPKM
SCHEMBL8777213 0.65 SMN1; SMN2 (0.67) SMN1; SMN2TDP1DHFRTSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008112241-A1 METHODS AN COMPOSITIONS FOR TREATMENT OF AN INTERSTITIAL LUNG DISEASE ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-09-18 WO disclosed